{"name":"NEURALIS s.a.","slug":"neuralis-s-a","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPbmFPNlB4b1lPOXpkV1NZVkRMUDVOR2xGakZaYWxreDNfemN0b1VNV3E4TnplWFVhdzdFaGRlUE9VZmtIRDVsNWhObkRyUEZKbHFoNksxd2E2emtzTkpPeDNyRkpUa01ISl9ySXRLRDNlSDNrVXQ4blFrdklrcUhnZHI4dHZ6ZXJCamIzWjNJWFUyS3ZUaXJmaHpkT0Y1eTdqSUVoa0E2aw?oc=5","date":"2024-06-12","type":"regulatory","source":"Pharmaceutical Technology","summary":"Bankrupt Mithra cashes in on remaining assets for $188.2m - Pharmaceutical Technology","headline":"Bankrupt Mithra cashes in on remaining assets for $188.2m","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}